Ads
related to: MERCK- AAV Reference Standards
Essential AAV Reference Standards
Full & Empty Capsids of 6 Serotypes
- Cell Therapy Production
Cell Therapy Manufacturing Services
From Clinical To Commercial
- GMP Adenovirus Services
cGMP-compliant & fully scalable
Viral vector manufacturing
- GMP QC Services
Viral Vector & Plasmid Assays
Quality, Sterility & Potency
- GMP Retrovirus Services
cGMP-compliant & fully scalable
Viral vector manufacturing
- GMP AAV Production
Extensive cGMP Experiences
Proven GMP Processes
- AAV Reference Standards
Search results
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 23 hours ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 14 hours agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 23 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 23 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 14 hours agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 15 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 22 hours agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 14 hours agoImage source: The Motley Fool. Merck (NYSE: MRK) Q1 2024 Earnings Call Apr 25, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 19 hours agoAlthough the revenue and EPS for Merck (MRK) give a sense of how its business performed in the...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 14 hours agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...